LONDON, UK / ACCESSWIRE / May 5, 2022 / Data Knights Acquisition Corp. (“Data Knights” or the “Company”) (NASDAQ:DKDCA)(NASDAQ:DKDCW), a special purpose acquisition company, today announced the deposit of a total of $1,150,000 into the Company’s trust account for its public shareholders, representing $0.10 per public share, which allows the Company to extend the period it has to complete its initial business combination by three months from May 11, 2022 to August 11, 2022 (the “Extension”). The extension is the first of up to two three-month extensions permitted under the company’s incorporation documents.

The extension provides the Company with additional time to complete its initial business combination (the “Business Combination”) with OneMedNet Corporation, a Delaware corporation (“OneMedNet”), previously announced by the Company and OneMedNet on April 25 2022.

About Data Knights Acquisition Corp.

Data Knights Acquisition Corp. is a blank check corporation formed for the purpose of effecting a merger, stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or entities technology or software.

About OneMedNet Corporation

Founded in 2009, OneMedNet provides innovative solutions that unlock the significant value contained in healthcare providers’ clinical image archives. Using its proven OneMedNet iRWD™ solution, OneMedNet anonymizes, searches and securely maintains an archive of data locally, providing providers with a wealth of internal and third-party research opportunities. By leveraging this extensive network of federated providers, along with industry-leading technology and in-house clinical expertise, OneMedNet successfully meets the most rigorous requirements of RWD Life Science.

Caution Regarding Forward-Looking Statements

Certain statements contained in this press release constitute “forward-looking statements” within the meaning of the federal securities laws. Forward-looking statements may include, but are not limited to, statements regarding (i) real-world medical data industry trends, including changes in United States and state laws, regulations, and guidelines relating to OneMedNet products and services; (ii) OneMedNet’s growth prospects and OneMedNet’s market size; (iii) OneMedNet’s projected financial and operational performance, including relative to its competitors; (iv) new product and service offerings that OneMedNet may introduce in the future; (v) the potential transaction, including the implied enterprise value, the expected ownership structure after closing and the likelihood and ability of the parties to complete the potential transaction; (vi) the risk that the proposed business combination will not be completed in a timely manner or at all, which could adversely affect the price of Data Knights’ securities; (vii) failure to satisfy the conditions to the completion of the proposed business combination, including the approval of the proposed business combination by the shareholders of Data Knights Acquisition Corp. ; (viii) the effect of the announcement or expectation of the proposed business combination on the business relationships, performance and business of Data Knights or OneMedNet generally; (ix) the outcome of any legal proceedings brought against Data Knights or OneMedNet related to the proposed business combination or any related agreement; (x) the possibility of maintaining the listing of Data Knights on the Nasdaq; (xi) the price of Data Knights securities, including volatility resulting from changes in the competitive and regulated industry in which OneMedNet operates, variations in performance among competitors, changes in laws and regulations affecting OneMedNet’s business and changes in the combined capital structure; (xii) the ability to implement business plans, forecasts and other expectations after completion of the proposed business combination and to identify and realize additional opportunities; and (xiii) other statements regarding Data Knights’ or OneMedNet’s expectations, hopes, beliefs, intentions and strategies regarding the future.

In addition, any statement that refers to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, is a forward-looking statement. it uses the words “anticipate”, “believe”, “continue”, “could”, “estimate”, “expect”, “intend”, “prospect”, “may”, “might” , “plan”, “possible”, “potential”, “predict”, “project”, “should”, “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, therefore, are subject to risks and uncertainties.

You should carefully consider the risks and uncertainties described in the “Risk Factors” section of Data Knights Acquisition Corp.’s registration statement. on Form S-1, any proxy statement relating to the transaction, which should be filed by Data Knights Acquisition Corp. Corp with the SEC, other documents filed by Data Knights Acquisition Corp from time to time with the SEC, and all risk factors made available to you in connection with Data Knights Acquisition Corp., OneMedNet and the transaction. These forward-looking statements involve a number of risks and uncertainties (some of which are beyond the control of OneMedNet and Data Knights Acquisition Corp.) and other assumptions, which may cause actual results or performance to differ materially from those expressed or implied. by these forward-looking statements.

contacts:
Contact Investor
Shannon Devine
MZ Group North America
203-741-8811
[email protected]

THE SOURCE: Data Knights Acquisition Corp.

See the source version on accesswire.com:
https://www.accesswire.com/700359/Data-Knights-Acquisition-Corp-Confirms-Funding-to-Extend-Period-to-Consummate-Initial-Business-Combination